Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Oct 2016

VERMOX 500 mg chewable tablets: FDA approved

treatment of patients one year of age and older withgastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm)

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

VERMOX 500 mg chewable tablets

Janssen Pharmaceutical Research & Development, LLC

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

VERMOX 500 mg chewable tablets

(mebendazole)Orphan drug

Janssen Pharmaceutical Research & Development, LLC

Anthelmintic [EPC]

12.1 Mechanism of Action Mebendazole, a benzimidazole, is an anthelmintic [see Microbiology (12.4) ] .

Approved Oct 2016FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome.
Search all trials →
Search clinical trials for Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome

Recent News & Research

No recent news articles indexed yet for Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome.
Search PubMed for Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome

Browse all Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome news →

Specialist Network

No specialists currently listed for Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome.

View all Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome specialists →

Quick Actions